{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T05:04:43Z","timestamp":1789707883336,"version":"4.0.1"},"reference-count":55,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:00:00Z","timestamp":1789689600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The American Heart Association recently introduced Cardiovascular-kidney-metabolic (CKM) syndrome as an integrated clinical construct. Evidence based on a single assessment suggests that the novel composite biomarker, Cholesterol, High-density lipoprotein, and Glucose (CHG) index, is associated with cardiovascular disease (CVD) risk. To data, the association between cumulative CHG index and risk of CVD has not been sufficiently investigated, particularly in individuals with CKM syndrome stages 0-3. Thus, we aimed to investigate the impact of cumulative CHG index on CVD development in individuals with CKM syndrome stages 0\u20133 and compared the predictive performances of triglyceride-glucose (TyG) index and CHG index for CVD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Participants were recruited from the Kailuan Study, a large-scale prospective cohort. The cumulative exposure was assessed using the time-weighted average (TWA) and exposure duration. The optimal cut-off values for TyG_TWA and CHG_TWA associated with CVD were derived using a survival-time method and were used to assess exposure duration of high TyG index\/CHG index. Multivariable Cox proportional hazard regression model was used to assess hazard ratio (HR) and 95% confidence interval (95% CI) for CVD incident in individuals with CKM syndrome stages 0-3.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We included 46,827 participants, of these, the mean age was 52.71 years, 76.80% were males. All participants were divided into four groups according to the quartiles (Q) of TyG_TWA and CHG_TWA (Q1-Q4), and exposure duration of high TyG index\/CHG index was quantified as 0 (reference), 2, 4, or 6 years. Over a mean follow-up of 11.08 years, 4,639 participants developed CVD. Compared with participants in Q1 group of CHG_TWA, the HRs (95% CIs) of CVD were 1.04 (0.95-1.14) for those in Q2 group, 1.13 (1.04-1.24) for those in Q3 group, and 1.23 (1.12-1.36) for those in Q4 group; compared with participants without exposure of high CHG index, the HR (95% CI) of CVD was increased by 41% (1.25-1.59) for those with 6 years exposure. Similar findings were observed in the analysis of cumulative exposure to TyG index with CVD. The association between TyG_TWA and CVD was linear, whereas the association of CHG_TWA with CVD was non-linear. The result of receiver operating characteristic curve analysis showed that CHG_TWA had a modestly higher discriminatory ability for CVD risk compared with TyG_TWA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In individuals with CKM syndrome stages 0-3, there was a significant association of high CHG_TWA\/TyG_TWA with the risk of CVD, with these associations being stronger with longer exposure duration to high TyG index and CHG index. CHG_TWA demonstrated a modestly higher discriminatory ability for CVD risk compared with TyG_TWA. Our findings suggest that longitudinal monitoring of CHG index and TyG index may provide additional information for CVD risk stratification in individuals with CKM syndrome stages 0-3.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2026.1950124","type":"journal-article","created":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T04:37:25Z","timestamp":1789706245000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparative associations of cumulative cholesterol-HDL-glucose index and triglyceride-glucose index with risk of cardiovascular disease in individuals with cardiovascular-kidney-metabolic syndrome stages 0-3: a prospective cohort study"],"prefix":"10.3389","volume":"17","author":[{"given":"Jiabaili","family":"Wang","sequence":"first","affiliation":[{"name":"CDUTCM-KEELE Joint Health and Medical Sciences Institute, Chengdu University of Traditional Chinese Medicine","place":["Chengdu, Sichuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Kailuan General Hospital","place":["Tangshan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Menghui","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Neurology, Kailuan General Hospital","place":["Tangshan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liming","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Kailuan General Hospital","place":["Tangshan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuntao","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Kailuan General Hospital","place":["Tangshan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1161\/cir.0000000000001184","article-title":"Cardiovascular-kidney-metabolic health: A presidential advisory from the American Heart Association","volume":"148","author":"Ndumele","year":"2023","journal-title":"Circulation"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1161\/cir.0000000000001186","article-title":"A synopsis of the evidence for the science and clinical management of cardiovascular-kidney-metabolic (CKM) syndrome: A scientific statement from the American Heart Association","volume":"148","author":"Ndumele","year":"2023","journal-title":"Circulation"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1111\/dom.14829","article-title":"Interconnection between cardiovascular, renal and metabolic disorders: A narrative review with a focus on Japan","volume":"24","author":"Kadowaki","year":"2022","journal-title":"Diabetes Obes Metab"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.124.038445","article-title":"Association of cardiovascular-kidney-metabolic syndrome with cognitive decline and dementia: The ARIC study insights","volume":"14","author":"Xie","year":"2025","journal-title":"J Am Heart Assoc"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1186\/s12889-025-22865-3","article-title":"Cardiovascular-kidney-metabolic syndrome modifies smoking-related risk for cardiovascular diseases: Findings from an observational cohort study in UK Biobank","volume":"25","author":"Liu","year":"2025","journal-title":"BMC Public Health"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1213\/ane.0000000000006975","article-title":"Cardiovascular-kidney-metabolic syndrome: Association with adverse events after major noncardiac surgery","volume":"139","author":"Roth","year":"2024","journal-title":"Anesth Analg"},{"key":"B7","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1016\/j.jacasi.2025.04.007","article-title":"Prevalence and mortality of cardiovascular-kidney-metabolic syndrome in China: A nationwide population-based study","volume":"5","author":"Zheng","year":"2025","journal-title":"JACC Asia"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2024.6892","article-title":"Prevalence of cardiovascular-kidney-metabolic syndrome stages in US adults, 2011-2020","volume":"331","author":"Aggarwal","year":"2024","journal-title":"Jama"},{"key":"B9","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s12933-022-01511-x","article-title":"Triglyceride-glucose index as a marker in cardiovascular diseases: Landscape and limitations","volume":"21","author":"Tao","year":"2022","journal-title":"Cardiovasc Diabetol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s12933-022-01546-0","article-title":"Relationship between the triglyceride-glucose index and risk of cardiovascular diseases and mortality in the general population: A systematic review and meta-analysis","volume":"21","author":"Liu","year":"2022","journal-title":"Cardiovasc Diabetol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1111\/jdi.14343","article-title":"A novel index for diagnosis of type 2 diabetes mellitus: Cholesterol, high density lipoprotein, and glucose (CHG) index","volume":"16","author":"Mansoori","year":"2025","journal-title":"J Diabetes Investig"},{"key":"B12","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s12933-025-02675-y","article-title":"Cholesterol, high-density lipoprotein, and glucose index versus triglyceride-glucose index in predicting cardiovascular disease risk: A cohort study","volume":"24","author":"Mo","year":"2025","journal-title":"Cardiovasc Diabetol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1161\/jaha.120.020180","article-title":"Cumulative serum uric acid and its time course are associated with risk of myocardial infarction and all-cause mortality","volume":"10","author":"Tian","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2022.01.045","article-title":"Association of cumulative blood pressure with cognitive decline, dementia, and mortality","volume":"79","author":"Li","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2019.4758","article-title":"Association of trajectory of cardiovascular health score and incident cardiovascular disease","volume":"2","author":"Wu","year":"2019","journal-title":"JAMA Netw Open"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1093\/eurjpc\/zwad398","article-title":"Life's Essential 8 and heart failure among patients with chronic kidney disease: The Kailuan Cohort Study","volume":"31","author":"Huo","year":"2024","journal-title":"Eur J Prev Cardiol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.2337\/dc17-0610","article-title":"Longitudinal change in fasting blood glucose and myocardial infarction risk in a population without diabetes","volume":"40","author":"Jin","year":"2017","journal-title":"Diabetes Care"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"B19","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1089\/met.2008.0034","article-title":"The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects","volume":"6","author":"Simental-Mend\u00eda","year":"2008","journal-title":"Metab Syndr Relat Disord"},{"key":"B20","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s12933-023-01936-y","article-title":"Association between cumulative atherogenic index of plasma exposure and risk of myocardial infarction in the general population","volume":"22","author":"Zhang","year":"2023","journal-title":"Cardiovasc Diabetol"},{"key":"B21","volume-title":"International Statistical Classification of Diseases and Related Health Problems, 10th Revision","year":"2010"},{"key":"B22","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1161\/01.cir.90.1.583","article-title":"Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents","volume":"90","author":"Tunstall-Pedoe","year":"1994","journal-title":"Circulation"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1161\/01.str.20.10.1407","article-title":"Stroke--1989. Recommendations on stroke prevention, diagnosis, and therapy. Report of the WHO Task Force on Stroke and other Cerebrovascular Disorders","volume":"20","year":"1989","journal-title":"Stroke"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.issn.0253-3758.2018.10.004","article-title":"Chinese guidelines for the diagnosis and treatment of heart failure 2018","volume":"46","year":"2018","journal-title":"Zhonghua Xin Xue Guan Bing Za Zhi"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehq278","article-title":"Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)","volume":"31","author":"Camm","year":"2010","journal-title":"Eur Heart J"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1161\/hypertensionaha.116.07381","article-title":"Longitudinal patterns of blood pressure, incident cardiovascular events, and all-cause mortality in normotensive diabetic people","volume":"68","author":"Wu","year":"2016","journal-title":"Hypertension"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.26599\/1671-5411.2025.01.008","article-title":"Chinese guidelines for the prevention and treatment of hypertension (2024 revision)","volume":"22","author":"Wang","year":"2025","journal-title":"J Geriatr Cardiol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.2337\/dci15-0012","article-title":"Update on prevention of cardiovascular disease in adults with type 2 diabetes mellitus in light of recent evidence: A scientific statement from the American Heart Association and the American Diabetes Association","volume":"38","author":"Fox","year":"2015","journal-title":"Diabetes Care"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.cn112148-20230119-00038","article-title":"Chinese guidelines for lipid management (2023)","volume":"51","year":"2023","journal-title":"Zhonghua Xin Xue Guan Bing Za Zhi"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-158-11-201306040-00007","article-title":"Evaluation and management of chronic kidney disease: Synopsis of the kidney disease: Improving global outcomes 2012 clinical practice guideline","volume":"158","author":"Stevens","year":"2013","journal-title":"Ann Intern Med"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1161\/circulationaha.116.022367","article-title":"Predicting the 10-year risks of atherosclerotic cardiovascular disease in Chinese population: The China-PAR Project (Prediction for ASCVD Risk in China)","volume":"134","author":"Yang","year":"2016","journal-title":"Circulation"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmpb.2019.05.023","article-title":"Evaluate Cutpoints: Adaptable continuous data distribution system for determining survival in Kaplan-Meier estimator","volume":"177","author":"Og\u0142uszka","year":"2019","journal-title":"Comput Methods Programs BioMed"},{"key":"B33","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1186\/s12933-022-01617-2","article-title":"Time course of the triglyceride glucose index accumulation with the risk of cardiovascular disease and all-cause mortality","volume":"21","author":"Tian","year":"2022","journal-title":"Cardiovasc Diabetol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-022-01456-1","article-title":"Cumulative triglyceride-glucose index is a risk for CVD: A prospective cohort study","volume":"21","author":"Cui","year":"2022","journal-title":"Cardiovasc Diabetol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s12933-023-01762-2","article-title":"Triglyceride-glucose index and triglyceride to high-density lipoprotein cholesterol ratio as potential cardiovascular disease risk factors: An analysis of UK Biobank data","volume":"22","author":"Che","year":"2023","journal-title":"Cardiovasc Diabetol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s12933-025-02662-3","article-title":"Comparison of triglyceride glucose index and modified triglyceride glucose indices in predicting cardiovascular diseases incidence among populations with cardiovascular-kidney-metabolic syndrome stages 0-3: A nationwide prospective cohort study","volume":"24","author":"Hong","year":"2025","journal-title":"Cardiovasc Diabetol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1186\/s12933-025-02842-1","article-title":"Triglyceride-glucose-related indices and risk of cardiovascular disease and mortality in individuals with cardiovascular-kidney-metabolic (CKM) syndrome stages 0-3: A prospective cohort study of 282,920 participants in the UK Biobank","volume":"24","author":"Liu","year":"2025","journal-title":"Cardiovasc Diabetol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1186\/s12933-024-02352-6","article-title":"Association between the triglyceride glucose-body mass index and future cardiovascular disease risk in a population with cardiovascular-kidney-metabolic syndrome stage 0-3: A nationwide prospective cohort study","volume":"23","author":"Li","year":"2024","journal-title":"Cardiovasc Diabetol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1186\/s12933-025-02754-0","article-title":"Association between cumulative changes of the triglyceride glucose index and incidence of stroke in a population with cardiovascular-kidney-metabolic syndrome stage 0-3: A nationwide prospective cohort study","volume":"24","author":"Lu","year":"2025","journal-title":"Cardiovasc Diabetol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1056\/nejm192908012010501","article-title":"Insulin resistance and bronze diabetes","volume":"201","author":"Root Howard","year":"1929","journal-title":"N Engl J Med"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacbts.2018.04.003","article-title":"Insulin resistance is a cardiovascular risk factor in humans","volume":"13","author":"Adeva-Andany","year":"2019","journal-title":"Diabetes Metab Syndr"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacbts.2018.04.003","article-title":"Potentiation of insulin signaling contributes to heart failure in type 2 diabetes: A hypothesis supported by both mechanistic studies and clinical trials","volume":"3","author":"Packer","year":"2018","journal-title":"JACC Basic Transl Sci"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.1979.237.3.E214","article-title":"Glucose clamp technique: A method for quantifying insulin secretion and resistance","volume":"237","author":"DeFronzo","year":"1979","journal-title":"Am J Physiol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1007\/bf00280883","article-title":"Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1111\/jch.14155","article-title":"Assessment of preferred methods to measure insulin resistance in Asian patients with hypertension","volume":"23","author":"Minh","year":"2021","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"B46","doi-asserted-by":"publisher","first-page":"4678526","DOI":"10.1155\/2020\/4678526","article-title":"Diagnostic accuracy of the triglyceride and glucose index for insulin resistance: A systematic review","volume":"2020","author":"S\u00e1nchez-Garc\u00eda","year":"2020","journal-title":"Int J Endocrinol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2023.22276","article-title":"Here's what to know about cardiovascular-kidney-metabolic syndrome, newly defined by the AHA","volume":"330","author":"Larkin","year":"2023","journal-title":"Jama"},{"key":"B48","doi-asserted-by":"publisher","first-page":"2358","DOI":"10.3390\/ijms20092358","article-title":"Adipose tissue dysfunction as determinant of obesity-associated metabolic complications","volume":"20","author":"Longo","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2021.154766","article-title":"Insulin resistance, cardiovascular stiffening and cardiovascular disease","volume":"119","author":"Hill","year":"2021","journal-title":"Metabolism"},{"key":"B50","doi-asserted-by":"publisher","first-page":"101674","DOI":"10.1016\/j.arr.2022.101674","article-title":"The pancreatic \u03b2-cell in ageing: Implications in age-related diabetes","volume":"80","author":"Tudur\u00ed","year":"2022","journal-title":"Ageing Res Rev"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1042\/cs20100476","article-title":"Aging and vascular endothelial function in humans","volume":"120","author":"Seals","year":"2011","journal-title":"Clin Sci (Lond)"},{"key":"B52","doi-asserted-by":"publisher","first-page":"590","DOI":"10.14336\/ad.2017.0430","article-title":"Age-related impairment of vascular structure and functions","volume":"8","author":"Xu","year":"2017","journal-title":"Aging Dis"},{"key":"B53","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1038\/s41392-025-02346-0","article-title":"Arterial stiffness and vascular aging: mechanisms, prevention, and therapy","volume":"10","author":"Herzog","year":"2025","journal-title":"Signal Transduct Target Ther"},{"key":"B54","doi-asserted-by":"publisher","first-page":"11188","DOI":"10.3390\/ijms252011188","article-title":"The implications of aging on vascular health","volume":"25","author":"Ahmed","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B55","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1186\/s12933-024-02457-y","article-title":"Trajectories of triglyceride-glucose index changes and their association with all-cause and cardiovascular mortality: a competing risk analysis","volume":"23","author":"Lee","year":"2024","journal-title":"Cardiovasc Diabetol"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1950124\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T04:37:33Z","timestamp":1789706253000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1950124\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,18]]},"references-count":55,"alternative-id":["10.3389\/fendo.2026.1950124"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1950124","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,18]]},"article-number":"1950124"}}